What Nucleus Global does

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. Founded in 1986 by Stephen Cameron in London, the firm delivers science-led communications services spanning strategic planning, publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications covering HEOR, market access, and pricing/reimbursement. The company operates a portfolio of twelve integrated service modules delivered through an in-house creative digital agency and approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia.

The firm's technology stack centers on its services portfolio plus access to iON AI, an AI-powered intelligence platform launched in March 2025 by parent Inizio Medical to address Medical Affairs challenges through text-based generative capabilities. Core delivery relies on scientific writing expertise, journal publications workflows, and creative/digital production rather than proprietary software products. The platform architecture, underlying AI models, and training data assets are not publicly disclosed.

Nucleus Global operates a B2B professional services revenue model with quote-based engagements and long-term enterprise partnerships. The go-to-market motion is sales-led, targeting large pharma companies through strategic account management and Senior Vice Presidents overseeing Growth Operations and Business Growth and Strategy. Pricing is not publicly disclosed. The company holds a 2024 MM+M Gold Award for Medical Communications, Education or Affairs Agency of the Year and serves 90-plus clients globally, with named enterprise accounts including top-tier pharmaceutical firms. Nucleus Global is a subsidiary of Inizio Medical, which is owned by Copec, and operates alongside sister agencies Ashfield MedComms, ApotheCom, and MEDiSTRAVA within the broader Inizio Medical network.

Name

Nucleus Global

Legal name

Nucleus Global

Website

https://nucleusglobal.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. The firm delivers scientific publications, medical education, and strategic communications through approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia, as part of the Inizio Medical network.

Ownership category

akta.pro rank

Product category

Medical Communications Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Medical communications services
• Scientific publications planning
• Pharmaceutical communications agency
• Medical affairs consulting
• Healthcare communications

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Communications Services: Professional services revenue model providing medical communications consulting to pharmaceutical, biotech, and medical device industries. Services include strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Nucleus Global is a global medical communications agency delivering strategic, scientific, and creative communications services to pharmaceutical, biotechnology, and medical device companies. Its core offering spans strategic planning, scientific publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement). The agency also leverages the parent-group iON AI platform to support Medical Affairs capabilities.

Product overview

Nucleus Global is a global medical communications agency and part of Inizio Medical, offering a portfolio of integrated service modules for the pharmaceutical, biotech, and medical device industries. The core offering includes strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications. The company has also launched iON AI, an AI-powered intelligence platform specifically designed to transform Medical Affairs capabilities. Services are delivered through a global team of approximately 750-900 professionals across Europe, US, and APAC regions, with internal creative and digital capabilities integrated across all projects.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategic Planning and Support Develops insight-driven communications strategies that translate into results-driven plans of action for pharmaceutical, biotechnology, and medical device clients.
• Publications Planning and Execution Accurate, transparent, and compliant editorial support focused on first-submission acceptance from leading journals, covering scientific publications for pharmaceutical and biotech clients.
• Promotional Medical Communications Science-backed commercial strategy design and implementation that moves HCP mindset and maximizes a brand's market potential for pharmaceutical clients.
• Medical Education Turns data and research into engaging, creative educational content delivered in print, digital, and virtual media formats for healthcare professional audiences.
• External Expert Engagement Identifies, maps, engages, and develops relationships with healthcare opinion leaders using best practices for collaboration on behalf of pharma and biotech clients.
• Scientific Event Management Manages scientific events from advisory boards to international symposia, supporting both virtual and in-person formats for pharmaceutical clients.
• Patient Engagement Connects brands to patients and patient advocates throughout the product lifecycle with clear, creative, and accessible communications.
• Internal Communications and Training Helps brand teams achieve internal alignment and collaboration through training and communications programs.
• Creative Design Provides leading-edge technology paired with creativity and visual design for data-driven communications across print, digital, and virtual media.
• Digital Solutions Creates digital solutions at the intersection of technology and scientific expertise for modern audiences ranging from medical experts to patients.
• Clinical Trial Support Provides streamlined approaches for clinical trials from recruitment to results with deliberate strategy infusion for pharmaceutical and biotech clients.
• Value Communications Provides strategic planning and tactical communications support for HEOR, market access, pricing and reimbursement, and epidemiology programs.
• iON AI AI-powered intelligence platform built to address the distinct challenges of Medical Affairs. Provides AI-powered capabilities for pharmaceutical and healthcare Medical Affairs teams, supporting scientific and medical information content generation.

Quantifiable outcome

• Extended services to 24-hour/day coverage through APAC team presence
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Inizio MedicalcoreOthersNucleus Global is part of Inizio Medical, a global healthcare consulting and communications group. Inizio Medical provides Nucleus Global with synergies from its global network of offices and access to AI-powered technology platforms like iON AI. The Inizio Medical group includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA.
• Inizio Medical Network (Ashfield MedComms, ApotheCom, MEDiSTRAVA)coreOthersNucleus Global forms part of Inizio Medical which includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA. This unique position within an international network provides expanded capabilities and resources across medical communications and healthcare consulting.
• International Society of Medical Publications Professionals (ISMPP)minorStrategic or Co-development PartnerNucleus Global APAC team members are active in ISMPP, driving educational activities, developing region-specific guidance on key medcomms deliverables, and contributing to the advancement of the medcomms profession through publications and professional development.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Ashfield MedComms: Sister agency under Inizio Medical offering medical communications, publications, and medical affairs services to pharma and biotech. Direct peer operating in the same category, same parent network, and targeting the same enterprise pharma client base as Nucleus Global.
• OPEN Health: Global medical communications and HEOR agency offering publications, medical affairs, market access, and patient engagement. Direct peer with overlapping service modules and similar enterprise pharma client base as Nucleus Global.
• Fishawack Health: Global medical communications and consulting agency serving pharma, biotech, and medtech with publications, medical affairs, and creative services. Direct independent peer with comparable full-service MedComms capabilities and similar top-10 pharma client base.
• ApotheCom: Sister Inizio Medical agency providing medical communications, publications planning, and scientific content services to biopharma. Direct peer in the same MedComms category, sharing the Inizio Medical network and competing for the same pharma clients as Nucleus Global.
• MEDiSTRAVA: Sister agency within Inizio Medical focused on medical communications and scientific content for pharma and biotech. Direct peer offering substantially the same service modules (publications, medcomms, digital) as Nucleus Global within the same parent group.

Broad incumbents

• Real Chemistry: Data-driven healthcare marketing and communications agency offering medcomms, PR, and analytics. Broad incumbent peer competing for pharma communications budgets with proprietary data and AI capabilities Nucleus Global does not own.
• CMC Connect (IPG Health): Medical communications and scientific engagement agency within IPG Health, serving top-20 pharma with publications and medcomms. Broad incumbent peer with comparable services, overlapping client base, and the backing of a major holding company's healthcare network.
• McCann Health Medical Communications: Global healthcare communications network within McCann Worldgroup offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global but at significantly larger scale and creative breadth.
• Syneos Health Communications: Large CRO and commercialization platform with a medical communications arm serving pharma and biotech. Broad incumbent with deeper clinical development capabilities but overlapping publications and medcomms services versus Nucleus Global.

Others

• Havas Life: Global healthcare communications network within Havas offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global at significantly larger scale and creative breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nucleusglobal
• Facebookfacebook.com/TheNucleusGroup
• LinkedInlinkedin.com/company/the-nucleus-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nucleus Global